MIA News Archives

Researchers interviewed people who were given medical advice to discontinue antidepressants.

MIA's Richard Sears interviews psychotherapist Anne Guy about working with clients withdrawing from psychiatric drugs.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

A new study reported on in Medscape, examined risk factors for misuse of benzodiazepines (drugs such as Xanax, Ativan, and Klonopin). The researchers found that patients who had been prescribed the medication on an as-needed basis were more likely to end up abusing it than those who had been prescribed a standing dose.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.

A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.

A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.

A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.

After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.

A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....

Qualitative study finds that both internal resources and systemic factors play a role in antipsychotic discontinuation outcomes.

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

Researchers found some antipsychotics to be worse than others for causing sexual dysfunction.

Benzodiazepine medications that are commonly used for calming or sedating people can sometimes apparently cause violent or aggressive responses in some people, according to...

Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.

Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.